These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33045869)

  • 1. A Single Injection of an Optimized Adeno-Associated Viral Vector into Cerebrospinal Fluid Corrects Neurological Disease in a Murine Model of GM1 Gangliosidosis.
    Hinderer C; Nosratbakhsh B; Katz N; Wilson JM
    Hum Gene Ther; 2020 Nov; 31(21-22):1169-1177. PubMed ID: 33045869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous delivery of adeno-associated viral gene therapy in feline GM1 gangliosidosis.
    Gross AL; Gray-Edwards HL; Bebout CN; Ta NL; Nielsen K; Brunson BL; Lopez Mercado KR; Osterhoudt DE; Batista AR; Maitland S; Seyfried TN; Sena-Esteves M; Martin DR
    Brain; 2022 Apr; 145(2):655-669. PubMed ID: 34410345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complete correction of enzymatic deficiency and neurochemistry in the GM1-gangliosidosis mouse brain by neonatal adeno-associated virus-mediated gene delivery.
    Broekman ML; Baek RC; Comer LA; Fernandez JL; Seyfried TN; Sena-Esteves M
    Mol Ther; 2007 Jan; 15(1):30-7. PubMed ID: 17164772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic AAV9 gene transfer in adult GM1 gangliosidosis mice reduces lysosomal storage in CNS and extends lifespan.
    Weismann CM; Ferreira J; Keeler AM; Su Q; Qui L; Shaffer SA; Xu Z; Gao G; Sena-Esteves M
    Hum Mol Genet; 2015 Aug; 24(15):4353-64. PubMed ID: 25964428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Biomarkers of Human GM1 Gangliosidosis Reflect the Clinical Efficacy of Gene Therapy in a Feline Model.
    Gray-Edwards HL; Regier DS; Shirley JL; Randle AN; Salibi N; Thomas SE; Latour YL; Johnston J; Golas G; Maguire AS; Taylor AR; Sorjonen DC; McCurdy VJ; Christopherson PW; Bradbury AM; Beyers RJ; Johnson AK; Brunson BL; Cox NR; Baker HJ; Denney TS; Sena-Esteves M; Tifft CJ; Martin DR
    Mol Ther; 2017 Apr; 25(4):892-903. PubMed ID: 28236574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice.
    Chen JC; Luu AR; Wise N; Angelis R; Agrawal V; Mangini L; Vincelette J; Handyside B; Sterling H; Lo MJ; Wong H; Galicia N; Pacheco G; Van Vleet J; Giaramita A; Fong S; Roy SM; Hague C; Lawrence R; Bullens S; Christianson TM; d'Azzo A; Crawford BE; Bunting S; LeBowitz JH; Yogalingam G
    J Biol Chem; 2020 Sep; 295(39):13532-13555. PubMed ID: 31481471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AAV-mediated gene delivery in adult GM1-gangliosidosis mice corrects lysosomal storage in CNS and improves survival.
    Baek RC; Broekman ML; Leroy SG; Tierney LA; Sandberg MA; d'Azzo A; Seyfried TN; Sena-Esteves M
    PLoS One; 2010 Oct; 5(10):e13468. PubMed ID: 20976108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of distribution of mouse beta-galactosidase in the adult GM1-gangliosidosis brain.
    Broekman ML; Tierney LA; Benn C; Chawla P; Cha JH; Sena-Esteves M
    Gene Ther; 2009 Feb; 16(2):303-8. PubMed ID: 18818671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AAV9-coGLB1 Improves Lysosomal Storage and Rescues Central Nervous System Inflammation in a Mutant Mouse Model of GM1 Gangliosidosis.
    Liu S; Ma W; Feng Y; Zhang Y; Jia X; Tang C; Tang F; Wu X; Huang Y
    Curr Gene Ther; 2022; 22(4):352-365. PubMed ID: 35249485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pentasaccharide for monitoring pharmacodynamic response to gene therapy in GM1 gangliosidosis.
    Kell P; Sidhu R; Qian M; Mishra S; Nicoli ER; D'Souza P; Tifft CJ; Gross AL; Gray-Edwards HL; Martin DR; Sena-Esteves M; Dietzen DJ; Singh M; Luo J; Schaffer JE; Ory DS; Jiang X
    EBioMedicine; 2023 Jun; 92():104627. PubMed ID: 37267847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of active human beta-galactosidase gene (100 kb) into genome using HSV/AAV amplicon vector.
    Oehmig A; Cortés ML; Perry KF; Sena-Esteves M; Fraefel C; Breakefield XO
    Gene Ther; 2007 Jul; 14(14):1078-91. PubMed ID: 17460718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive behavioral and biochemical outcomes of novel murine models of GM1-gangliosidosis and Morquio syndrome type B.
    Przybilla MJ; Ou L; Tăbăran AF; Jiang X; Sidhu R; Kell PJ; Ory DS; O'Sullivan MG; Whitley CB
    Mol Genet Metab; 2019 Feb; 126(2):139-150. PubMed ID: 30528226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis.
    Matsuda J; Suzuki O; Oshima A; Ogura A; Noguchi Y; Yamamoto Y; Asano T; Takimoto K; Sukegawa K; Suzuki Y; Naiki M
    Glycoconj J; 1997 Sep; 14(6):729-36. PubMed ID: 9337086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient high-level expression of beta-galactosidase after transfection of fibroblasts from GM1 gangliosidosis patients with plasmid DNA.
    Balestrin RC; Baldo G; Vieira MB; Sano R; Coelho JC; Giugliani R; Matte U
    Braz J Med Biol Res; 2008 Apr; 41(4):283-8. PubMed ID: 18392450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired elastic-fiber assembly by fibroblasts from patients with either Morquio B disease or infantile GM1-gangliosidosis is linked to deficiency in the 67-kD spliced variant of beta-galactosidase.
    Hinek A; Zhang S; Smith AC; Callahan JW
    Am J Hum Genet; 2000 Jul; 67(1):23-36. PubMed ID: 10841810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A GM1 gangliosidosis mutant mouse model exhibits activated microglia and disturbed autophagy.
    Liu S; Feng Y; Huang Y; Jiang X; Tang C; Tang F; Zeng C; Liu L
    Exp Biol Med (Maywood); 2021 Jun; 246(11):1330-1341. PubMed ID: 33583210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Enzyme Replacement Therapy with a Recombinant β-Galactosidase-Lectin Fusion for CNS Delivery and Treatment of GM1-Gangliosidosis.
    Weesner JA; Annunziata I; Yang T; Acosta W; Gomero E; Hu H; van de Vlekkert D; Ayala J; Qiu X; Fremuth LE; Radin DN; Cramer CL; d'Azzo A
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation and characterization of recombinant feline beta-galactosidase for preclinical enzyme replacement therapy studies in GM1 gangliosidosis.
    Samoylova TI; Martin DR; Morrison NE; Hwang M; Cochran AM; Samoylov AM; Baker HJ; Cox NR
    Metab Brain Dis; 2008 Jun; 23(2):161-73. PubMed ID: 18421424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme replacement for GM1-gangliosidosis: Uptake, lysosomal activation, and cellular disease correction using a novel β-galactosidase:RTB lectin fusion.
    Condori J; Acosta W; Ayala J; Katta V; Flory A; Martin R; Radin J; Cramer CL; Radin DN
    Mol Genet Metab; 2016 Feb; 117(2):199-209. PubMed ID: 26766614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
    Kasperzyk JL; El-Abbadi MM; Hauser EC; D'Azzo A; Platt FM; Seyfried TN
    J Neurochem; 2004 May; 89(3):645-53. PubMed ID: 15086521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.